Thermal Measurement Device for Hydrocephalus
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new device, the Wireless Thermal Anisotropy Measurement Device, which measures how well a shunt (a tube used to drain fluid) functions in people with hydrocephalus, especially during headaches. The goal is to determine if the device can track changes in cerebrospinal fluid (CSF) flow without surgery. It targets individuals with hydrocephalus who already have a shunt and experience frequent headaches—at least 15 days a month. As an unphased trial, this study allows participants to contribute to innovative research that could enhance non-surgical monitoring of shunt function.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this device is safe for assessing CSF shunt flow?
Research has shown that wireless and non-invasive devices, like the one under study, can effectively monitor cerebrospinal fluid (CSF) flow in shunts. This capability helps identify problems without surgery or other invasive methods.
One study found these devices to be generally safe and easy for patients to use in daily life. As the device is non-invasive, it does not require insertion into the body, reducing the risk of complications.
Studies involving similar devices have reported no serious side effects, suggesting the treatment is well-tolerated by patients.12345Why are researchers excited about this trial?
Researchers are excited about the Wireless Thermal Anisotropy Measurement Device because it offers a novel way to manage chronic headaches in hydrocephalus patients with shunts. Unlike standard treatments that typically involve medication adjustments or surgical revisions, this device provides a non-invasive method to measure temperature changes that can indicate shunt function. By using wireless technology, it allows for real-time monitoring and potentially quicker interventions if a problem is detected. This could lead to better management of symptoms and improve the quality of life for patients who suffer from frequent headaches.
What evidence suggests that this device is effective for assessing CSF shunt flow in hydrocephalus patients?
Research has shown that a new wireless device, used by participants in this trial, can effectively monitor cerebrospinal fluid (CSF) shunt flow. Studies have found that this non-invasive sensor accurately detects shunt flow in symptomatic patients. By using heat to track fluid movement, the device helps identify shunt issues. Early results suggest it could be a reliable tool for patients with hydrocephalus who experience headaches, potentially reducing the need for invasive tests.678910
Are You a Good Fit for This Trial?
This trial is for individuals with hydrocephalus who experience headaches. Participants will use a wireless device to measure CSF shunt flow during headache and non-headache periods. Specific eligibility criteria are not provided, but typically include being diagnosed with the condition and consenting to participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Measurement
Participants use the device to measure cerebrospinal fluid (CSF) shunt flow during headache and non-headache periods
Follow-up
Participants are monitored for safety and effectiveness after the measurement period
What Are the Treatments Tested in This Trial?
Interventions
- Wireless Thermal Anisotropy Measurement Device
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rhaeos, Inc.
Lead Sponsor